Morris Z. Rosenberg
Dr. Morris Rosenberg is founder and a consultant at MRosenberg BioPharma Consulting. He has over 25 years experience in the development of therapeutic agents to treat a variety of human diseases. He has participated in the development and launch of Adcetris, Avonex, Angiomax, Xigris, and Forteo. He played a key role over the past decade, as part of the executive management team at Seattle Genetics, in building a commercial biopharmaceutical company focused on the development of antibody-drug conjugate technology for the treatment of cancer and autoimmune disorders.